rs7355045
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005529.7(HSPG2):c.8464+143A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.804 in 979,460 control chromosomes in the GnomAD database, including 317,727 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.78 ( 46024 hom., cov: 32)
Exomes 𝑓: 0.81 ( 271703 hom. )
Consequence
HSPG2
NM_005529.7 intron
NM_005529.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.41
Publications
5 publications found
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
- Schwartz-Jampel syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Silverman-Handmaker type dyssegmental dysplasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- Schwartz-Jampel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-21845965-T-C is Benign according to our data. Variant chr1-21845965-T-C is described in ClinVar as [Benign]. Clinvar id is 1245045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.809 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.775 AC: 117918AN: 152070Hom.: 45976 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
117918
AN:
152070
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.809 AC: 669565AN: 827274Hom.: 271703 AF XY: 0.812 AC XY: 347087AN XY: 427708 show subpopulations
GnomAD4 exome
AF:
AC:
669565
AN:
827274
Hom.:
AF XY:
AC XY:
347087
AN XY:
427708
show subpopulations
African (AFR)
AF:
AC:
15026
AN:
21242
American (AMR)
AF:
AC:
26576
AN:
38280
Ashkenazi Jewish (ASJ)
AF:
AC:
17111
AN:
19206
East Asian (EAS)
AF:
AC:
29181
AN:
34788
South Asian (SAS)
AF:
AC:
51411
AN:
63282
European-Finnish (FIN)
AF:
AC:
29331
AN:
35928
Middle Eastern (MID)
AF:
AC:
2430
AN:
2864
European-Non Finnish (NFE)
AF:
AC:
466753
AN:
572356
Other (OTH)
AF:
AC:
31746
AN:
39328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
7122
14244
21366
28488
35610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.776 AC: 118021AN: 152186Hom.: 46024 Cov.: 32 AF XY: 0.774 AC XY: 57595AN XY: 74400 show subpopulations
GnomAD4 genome
AF:
AC:
118021
AN:
152186
Hom.:
Cov.:
32
AF XY:
AC XY:
57595
AN XY:
74400
show subpopulations
African (AFR)
AF:
AC:
29077
AN:
41488
American (AMR)
AF:
AC:
10852
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
3105
AN:
3472
East Asian (EAS)
AF:
AC:
4247
AN:
5170
South Asian (SAS)
AF:
AC:
3962
AN:
4828
European-Finnish (FIN)
AF:
AC:
8741
AN:
10614
Middle Eastern (MID)
AF:
AC:
244
AN:
294
European-Non Finnish (NFE)
AF:
AC:
55390
AN:
68000
Other (OTH)
AF:
AC:
1669
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1379
2758
4138
5517
6896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2877
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.